Sort
50,496 grants matching “lung cancer”
Novel agents for mitigation of radiation-induced pulmonary injury
$950,371Kathryn Dale Held · Massachusetts General Hospital · RC1 · FY2009 · AI
Prospective Study of Alaska Natives and American Indians
$950,117Alaska Native Tribal Health Consortium · R01 · FY2001 · CA
Targeted vaccines against pulmonary NTM infections in vulnerable populations
$950,092Rhea N Coler · Seattle Children'S Hospital · R01 · FY2025 · AI
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$950,045Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2019 · CA
Etiological Studies of Gastric Carcinoma
$950,043Louisiana State Univ Hsc New Orleans · P01 · FY2003 · CA
Pre-clinical validation and verification of a biology-guided radiation therapy system
$950,000Samuel Mazin · Reflexion Medical, Inc. · R44 · FY2020 · CA
Leveraging Diversity in Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores
$950,000David V Conti · University Of Southern California · U01 · FY2024 · CA
Methods for Etiologic Studies of Diet and Cancer
$949,851Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Next Generation Smart Nanoparticles
$949,761Jianghong Rao · Stanford University · U54 · FY2013 · CA
Shanghai Men's Health Study
$949,381Xiao-Ou Shu · Vanderbilt University Medical Center · UM1 · FY2016 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$949,175Joel L Weissfeld · University Of Pittsburgh At Pittsburgh · N01 · FY2010 · CA
Human metabolic variation as a window into cancer initiation and progression
$949,015Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2025 · CA
Molecular Dynamics Simulations Of Biological Macromolecules
$948,837Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Biospecimen procurement and tissue microarray manufacture for the CHTN
$948,531Christopher A. Moskaluk · University Of Virginia · UM1 · FY2022 · CA
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$948,345Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
Cancer Risk Reduction and Diet: A Cohort Study of Women
$948,106Wei Zheng · Vanderbilt University · R37 · FY2012 · CA
Immunotherapy for Malignant Mesothelioma
$947,902Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood
$947,748Abhijit Patel · Yale University · U01 · FY2022 · CA
NHGRI/DIR Genomics Core
$947,326Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2022 · HG
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
$947,195Powel H Brown · University Of Tx Md Anderson Can Ctr · UG1 · FY2019 · CA
Early Life Conditions, Survival, and Health: A Pedigree-Based Population Study
$947,091Ken R Smith · University Of Utah · R01 · FY2011 · AG
Assessing the integration of tobacco cessation treatment into lung cancer screening
$947,066Elyse R Park · Massachusetts General Hospital · R01 · FY2020 · CA
NRG Oncology Network Group Operations Center - BIQSFP
$946,881Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2021 · CA
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$946,675Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
$946,646Calvin J Kuo · Stanford University · U01 · FY2021 · CA